Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution.

Hou HA, Chou WC, Kuo YY, Liu CY, Lin LI, Tseng MH, Chiang YC, Liu MC, Liu CW, Tang JL, Yao M, Li CC, Huang SY, Ko BS, Hsu SC, Chen CY, Lin CT, Wu SJ, Tsay W, Chen YC, Tien HF.

Blood Cancer J. 2015 Jul 31;5:e331. doi: 10.1038/bcj.2015.59.

2.

Gradual Increase of Chronic Lymphocytic Leukemia Incidence in Korea, 1999-2010: Comparison to Plasma cell myeloma.

Lee SJ, Tien HF, Park HJ, Kim JA, Lee DS.

Leuk Lymphoma. 2015 Jul 1:1-19. [Epub ahead of print]

PMID:
26133722
3.

MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine.

Lu JW, Lin YM, Lai YL, Chen CY, Hu CY, Tien HF, Ou DL, Lin LI.

Med Oncol. 2015 Jul;32(7):206. doi: 10.1007/s12032-015-0650-7. Epub 2015 Jun 19.

PMID:
26087957
4.

High Incidences of Invasive Fungal Infections in Acute Myeloid Leukemia Patients Receiving Induction Chemotherapy without Systemic Antifungal Prophylaxis: A Prospective Observational Study in Taiwan.

Tang JL, Kung HC, Lei WC, Yao M, Wu UI, Hsu SC, Lin CT, Li CC, Wu SJ, Hou HA, Chou WC, Huang SY, Tsay W, Chen YC, Chen YC, Chang SC, Ko BS, Tien HF.

PLoS One. 2015 Jun 10;10(6):e0128410. doi: 10.1371/journal.pone.0128410. eCollection 2015.

5.

High Risk of Hepatitis B Reactivation among Patients with Acute Myeloid Leukemia.

Chen CY, Huang SY, Cheng A, Chou WC, Yao M, Tang JL, Tsay W, Sheng WH, Tien HF.

PLoS One. 2015 May 14;10(5):e0126037. doi: 10.1371/journal.pone.0126037. eCollection 2015.

6.

Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults.

Cheng CL, Li CC, Hou HA, Fang WQ, Chang CH, Lin CT, Tang JL, Chou WC, Chen CY, Yao M, Huang SY, Ko BS, Wu SJ, Tsay W, Tien HF.

BMC Cancer. 2015 May 2;15:344. doi: 10.1186/s12885-015-1376-9.

7.

Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia.

Chen YK, Hou HA, Tang JL, Jhuang JY, Lai YJ, Lee MC, Kuo YY, Chou WC, Liu CY, Lin CW, Chuang SS, Chen CY, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

PLoS One. 2015 Mar 20;10(3):e0119831. doi: 10.1371/journal.pone.0119831. eCollection 2015.

8.

Adult T-cell lymphoma/leukemia presenting as isolated central nervous system T-cell lymphoma.

Ma WL, Li CC, Yu SC, Tien HF.

Case Rep Hematol. 2014;2014:917369. doi: 10.1155/2014/917369. Epub 2014 Dec 23.

9.

Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.

Chen CY, Sheng WH, Huang SY, Chou WC, Yao M, Tang JL, Tsay W, Tien HF, Hsueh PR.

J Antimicrob Chemother. 2015 May;70(5):1531-8. doi: 10.1093/jac/dku540. Epub 2015 Jan 3.

PMID:
25558079
10.

A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients.

Chuang MK, Chiu YC, Chou WC, Hou HA, Chuang EY, Tien HF.

Leukemia. 2015 May;29(5):1051-9. doi: 10.1038/leu.2014.333. Epub 2014 Nov 27.

PMID:
25428263
11.

SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.

Inoue D, Kitaura J, Matsui H, Hou HA, Chou WC, Nagamachi A, Kawabata KC, Togami K, Nagase R, Horikawa S, Saika M, Micol JB, Hayashi Y, Harada Y, Harada H, Inaba T, Tien HF, Abdel-Wahab O, Kitamura T.

Leukemia. 2015 Apr;29(4):847-57. doi: 10.1038/leu.2014.301. Epub 2014 Oct 13.

PMID:
25306901
12.

Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations.

Chou SC, Tang JL, Hou HA, Chou WC, Hu FC, Chen CY, Yao M, Ko BS, Huang SY, Tsay W, Chen YC, Tien HF.

Leuk Res. 2014 Nov;38(11):1278-84. doi: 10.1016/j.leukres.2014.08.012. Epub 2014 Aug 24.

PMID:
25260824
13.

GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.

Hou HA, Lin YC, Kuo YY, Chou WC, Lin CC, Liu CY, Chen CY, Lin LI, Tseng MH, Huang CF, Chiang YC, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

Ann Hematol. 2015 Feb;94(2):211-21. doi: 10.1007/s00277-014-2208-8. Epub 2014 Sep 21.

PMID:
25241285
14.

The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.

Kuo YY, Hou HA, Chen YK, Li LY, Chen PH, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Chou WC, Liu CY, Tang JL, Yao M, Tien HF.

Haematologica. 2014 Dec;99(12):1799-807. doi: 10.3324/haematol.2014.107821. Epub 2014 Sep 5.

15.

Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.

Hsiao LT, Tien HF, Kuo CY, Wu JH, Hou HA, Wang MC, Liu CY, Chen PM, Chiou TJ.

Hematol Oncol. 2014 Aug 11. doi: 10.1002/hon.2161. [Epub ahead of print]

PMID:
25111959
16.

Guidelines for treating iron overload in myelodysplastic syndromes: a Taiwan consensus statement.

Ko BS, Chang CS, Chang MC, Chen TY, Chiou TJ, Chiu CF, Huang WL, Kao WY, Lan YJ, Lin SF, Tan TD, Tang JL, Tzeng CH, Wang PN, Yet SP, Tien HF.

Int J Hematol. 2014 Jul;100(1):7-15. doi: 10.1007/s12185-014-1607-x. Epub 2014 Jun 13.

PMID:
24924953
17.

IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients.

Yang YT, Hou HA, Liu CY, Lin CC, Chou WC, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Li CC, Kuo YY, Huang SY, Ko BS, Chen CY, Hsu SC, Lin CT, Wu SJ, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 Sep;89(9):E142-9. doi: 10.1002/ajh.23765. Epub 2014 Jun 19.

PMID:
24845799
18.

SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.

Lin CC, Hou HA, Chou WC, Kuo YY, Wu SJ, Liu CY, Chen CY, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Tang JL, Yao M, Huang SY, Hsu SC, Ko BS, Tsay W, Chen YC, Tien HF.

Am J Hematol. 2014 Aug;89(8):E109-15. doi: 10.1002/ajh.23734. Epub 2014 Apr 28.

PMID:
24723457
19.

MicroRNA let-7a-3 gene methylation is associated with karyotyping, CEBPA promoter methylation, and survival in acute myeloid leukemia.

Ko YC, Fang WH, Lin TC, Hou HA, Chen CY, Tien HF, Lin LI.

Leuk Res. 2014 May;38(5):625-31. doi: 10.1016/j.leukres.2014.03.008. Epub 2014 Mar 19.

PMID:
24703161
20.

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.

Huang SY, Lin CW, Lin HH, Yao M, Tang JL, Wu SJ, Chen YC, Lu HY, Hou HA, Chen CY, Chou WC, Tsay W, Chou SJ, Tien HF.

Ann Hematol. 2014 Aug;93(8):1371-80. doi: 10.1007/s00277-014-2063-7. Epub 2014 Apr 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk